LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA – CVS Health Corporation Transaction History
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA portfolio value:
$964,000
portfolio value
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA quarter portfolio value change:
+2.92%
quarter
CVS Health Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -2.79% | -290 shares | 0 | $95.37 | 10.11K |
| Q2 2022 | share | Increase | +1.21% | 124 shares | -76K | $92.66 | 10.40K |
| Q1 2022 | share | Decrease | -5.72% | -624 shares | -85K | $101.21 | 10.27K |
| Q4 2021 | share | Decrease | -17.51% | -2.31K shares | 3K | $103.68 | 10.90K |
| Q3 2021 | share | Decrease | -1.51% | -203 shares | 2K | $84.37 | 13.21K |
| Q2 2021 | share | Decrease | -48.66% | -12.71K shares | -846K | $82.46 | 13.42K |
| Q1 2021 | share | Increase | +0.07% | 18 shares | 182K | $73.86 | 26.13K |
| Q4 2020 | share | Decrease | -8.51% | -2.43K shares | 117K | $66.61 | 26.12K |
| Q3 2020 | share | Decrease | -49.88% | -28.41K shares | -2.03M | $56.48 | 28.55K |
| Q2 2020 | share | Decrease | -48.41% | -53.45K shares | -2.85M | $62.34 | 56.96K |
| Q1 2020 | share | Decrease | -45.48% | -92.11K shares | -8.49M | $56.46 | 110.42K |
| Q4 2019 | share | Decrease | -17.60% | -43.25K shares | -456K | $70.23 | 202.53K |
| Q3 2019 | share | Decrease | -19.98% | -61.38K shares | -1.23M | $59.17 | 245.79K |
| Q2 2019 | share | Decrease | -3.92% | -12.53K shares | -504K | $50.67 | 307.17K |
| Q1 2019 | share | Decrease | -8.65% | -30.26K shares | -5.68M | $49.67 | 319.70K |
| Q4 2018 | share | Decrease | -0.60% | -2.13K shares | -4.78M | $59.89 | 349.97K |
| Q3 2018 | share | Decrease | -5.95% | -22.26K shares | 3.62M | $71.46 | 352.10K |
| Q2 2018 | share | Decrease | -9.58% | -39.64K shares | -1.66M | $57.97 | 374.36K |
| Q1 2018 | share | Decrease | -8.04% | -36.19K shares | -6.88M | $55.62 | 414.01K |
| Q4 2017 | share | Decrease | -2.57% | -11.89K shares | -4.93M | $64.42 | 450.20K |
| Q3 2017 | share | Decrease | -3.16% | -15.06K shares | -562K | $71.78 | 462.10K |
| Q2 2017 | share | Increase | +0.58% | 2.75K shares | 898K | $70.57 | 477.16K |
| Q1 2017 | share | Decrease | -0.72% | -3.44K shares | -465K | $68.41 | 474.41K |
| Q4 2016 | share | Decrease | -1.91% | -9.28K shares | -5.64M | $68.35 | 477.85K |
| Q3 2016 | share | Increase | +31.32% | 116.17K shares | 7.83M | $76.7 | 487.14K |
| Q2 2016 | share | Increase | +10.65% | 35.69K shares | 738K | $82.16 | 370.96K |
| Q1 2016 | share | Increase | +8.47% | 26.17K shares | 4.55M | $88.65 | 335.27K |